DGAP-News: MeVis Medical Solutions AG: MeVis reports strong

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: MeVis Medical Solutions AG: MeVis reports strong third quarter

DGAP-News: MeVis Medical Solutions AG / Key word(s): 9-month figures/Interim Report MeVis Medical Solutions AG: MeVis reports strong third quarter 17.11.2014 / 07:40 --------------------------------------------------------------------- MeVis reports strong third quarter Earnings per share after first three quarters 17 % higher year on year - Third quarter sales of EUR 3.6 million exceed first two quarters of 2014 (prev. year: EUR 3.6 million) - Sales of EUR 9.7 million after first three quarters in line with previous year - Share of maintenance business remains stable at 44 % (prev. year: 45 %) - Earnings before interest and taxes (EBIT) slightly lower at EUR 3.2 million (prev. year: EUR 3.5 million), but EBIT margin remains strong at 33 % - Profit for the period up sharply to EUR 3.5 million (prev. year: EUR 2.9 million) thanks to good financial result - Earnings per share up 17 %, from EUR 1.71 to EUR 2.01 - Liquidity of EUR 15.5 million as of September 30, 2014 (end of 2013: EUR 13.5 million) - Software solution for lung screening complete, first industrial customer acquired Bremen, November 17, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading medical imaging software company, today announced its results for the first three quarters of 2014. Sales in the third quarter of 2014 amounted to EUR 3,599 k, slightly above the previous year's level (EUR 3,554 k) and well in excess of the first two quarters of 2014. Sales in the first nine months were just slightly lower year on year at EUR 9,661 k (prev. year: EUR 9,712 k). Sales in the new license business stabilized at EUR 5,067 k (prev. year: EUR 5,034 k), while sales in the maintenance business were down slightly by 3 % to EUR 4,293 k, accounting for 44 % of total sales. Sales in the Digital Mammography segment improved by 3 % to EUR 7,280 k (prev. year: EUR 7,087 k) while sales in the Other Diagnostics segment fell by 9 % to EUR 2,381 k (prev. year: EUR 2,625 k). Operating costs rose in the reporting period 2014 primarily on the back of higher staff costs, which increased by 6 % to EUR 5,208 k (prev. year: EUR 4,895 k), particularly due to minor salary increases and a slight increase in the number of employees. Other operating expenses rose by 18 % to EUR 1,542 k (prev. year: EUR 1,303 k), which was partly offset by the transfer of costs to the MeVis BreastCare joint venture, as is reflected in the sharp increase in other operating income. Capitalized development expenses rose slightly to EUR 1,163 k (prev. year: EUR 1,075 k). However, this figure is expected to subside considerably in future. EBITDA (earnings before interest, taxes, depreciation and amortization) was down by 7 %, from EUR 4,697 k to EUR 4,373 k year on year due to higher costs and the fact that sales remained more or less stable. Depreciation and amortization came to EUR 1,223 k, on par with the previous year, resulting in EBIT (earnings before interest and taxes) of EUR 3,150 k (down a sharp 10 % on the previous year's figure of EUR 3,485 k); the EBIT margin remained strong at 33 % (prev. year: 36 %). The financial result was up sharply by EUR 1,100 k to EUR 775 k year on year, thanks mainly to the development of the US dollar, the considerable improvement in earnings at joint venture MeVis BreastCare and higher interest income. Tax expenses increased by EUR 258 k to EUR 469 k. After-tax earnings increased by EUR 507 k to EUR 3,456 k, which is equivalent to earnings per share of EUR 2.01 (prev. year: EUR 1.71). Cash and cash equivalents were up by a considerable EUR 2,069 k to EUR 15,519 k as of September 30, 2014 compared to the end of 2013. "In view of the development of business so far, we are very confident that we can meet our forecast for the year," commented Dr. Robert Hannemann, CFO of MeVis Medical Solutions AG. "Given that fiscal year 2013 was very successful, we anticipate a slight decline in sales to between EUR 12.0 million and EUR 12.5 million in 2014. The development of EBIT will in our view be significantly impacted by the expected slight decline in sales and a marginal increase in costs. We also anticipate considerably lower capitalized development expenses in the fourth quarter. We expect EBIT to fall slightly to between EUR 3.0 million and EUR 3.5 million. Liquidity is forecast to rise to between EUR 15.0 million and EUR 16.0 million in 2014 as a result of sustained positive cash flows from operating activities". "We are pleased that we were able to complete our Veolity software solution for the growth market of lung cancer screening in the third quarter," states Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. "The conclusion of a contract with an important industrial customer in the third quarter confirms our conviction that other market players see lung screening as a lucrative market." Mr. Kirchhoff added: "We very much welcome the decision of the CMS (Centers for Medicare & Medicaid Services) of November 10th, 2014 that the national health insurances Medicare and Medicaid will assume the reimbursement of costs for lung screening in the United States. Through this decision a lung screening program throughout the United States can be implemented in the coming years." The Company's financial reports can be downloaded from the following website: http://www.mevis.de/ir_finanzberichte.html?&L=1 --------------------------------------------------------------------- 17.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: ir@mevis.de Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 297437 17.11.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 89

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 88

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 114

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 149

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 286

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 108

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
Snowrise Targets the Blind Spots in CPG Sales Data

Updated Category News Views 128

A sales total can look healthy while the floorboards are quietly rotting underneath it. That is the uncomfortable CPG problem Snowrise is aiming at: brands know what moved last quarter, but often cannot identify which stores, channels, communities, or promotions actually created the result. Plenty of management teams still steer by topline revenue, net distribution gains,...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 125

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 36

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading

Top 5 Most Recently Viewed Articles

Current Trends in Short Interest Impacting PayPal Stock

Updated Category News Views 262

Understanding PayPal Holdings Inc and Its Market Position PayPal Holdings Inc (NYSE: PYPL) remains a prominent player in the digital payments space, continuing to see fluctuations in its market sentiment. Recently, the company has noted a significant increase in short interest as a percentage of float, climbing by 11.57%. This rise has brought the total number of shares...

Continue Reading
WillScot Plans Upcoming Earnings Call and Webcast for Q1

Updated Category News Views 152

WillScot Holdings Corporation to Share Q1 Results WillScot Holdings Corporation, a renowned leader in providing innovative temporary flexible space solutions, has announced its schedule for releasing the financial results for the first quarter of 2025. This eagerly anticipated announcement is set to take place on May 1, 2025, after market close, allowing investors and...

Continue Reading
Denarius' Bold Move: Debentures Target Early Exit

Updated Category News Views 53

Treading Against Debentures: Denarius' Maneuver Denarius Metals Corp. doesn't seem keen on playing it safe with convertible debentures tying up its business. Jaw-dropping numbers in news like this make you stop and wonder: Is this strategy brilliance, or just a roll of the dice? Time-Pressured Decisions Denarius Metals, trading as OTCQX: DNRSF, has kicked off a whirlwind...

Continue Reading
Katten Partners Recognized Among Top Experts in Crypto Sector

Updated Category News Views 185

Katten Partners Shine in Crypto Industry Recognition Katten, a well-respected law firm, has gained significant attention for its leadership in the evolving digital asset landscape. Three of its distinguished partners have been recognized by Citywealth, a leading publication in the private wealth sector, for their exceptional contributions to the cryptocurrency domain. The...

Continue Reading
Anticipating Logitech International's Earnings Success

Updated Category News Views 160

Anticipating Logitech International's Earnings Success Logitech International (NASDAQ: LOGI) is gearing up for its next quarterly earnings announcement, and investors are keenly observing potential developments. As the company prepares to report earnings, expectations are high for positive news regarding financial forecasts and results. Analyst Predictions for Earnings...

Continue Reading